147.34 USD
↗ 4.56 (3.19%)AT CLOSE (03:59 PM EDT)
Belite Bio, Inc American Depositary Shares
BLTENASDAQ • USD
158.32
↗ 10.98 (7.45%)
POST MARKET (AS OF 07:51 PM EDT)
Post Market
AS OF 07:51 PM EDT
158.32
↗ 10.98 (7.45%)
Market: OPEN
BLTE is currently priced at $158.32. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. This is driven by a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Oct 19, 2026.
Open?$143.46
High?$150.47
Low?$142.94
Prev. Close?$142.78
Volume?164.4K
Avg. Volume?N/A
VWAP?$145.89
Bid / Ask
Bid?$125.05 × 100
Ask?$190.98 × 100
Spread?$65.93
Midpoint?$158.02
Valuation & Ratios
Market Cap?5.8B
Shares Out?N/A
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
Themes
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestHigh
Short Interest?1.1M
Days to Cover?7.3
Avg Daily Volume145.2K
Settlement Date2026-09-30